Latest News and Press Releases

New York, United States, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Pharmaceuticals known as atrial fibrillation (AF) medicines are employed in the treatment of atrial fibrillation, a prevalent cardiac...

CAMBRIDGE, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (“Anthos”), a transformative, clinical-stage biopharmaceutical company developing innovative therapeutic options for the...

CAMBRIDGE, Mass., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (“Anthos”), a transformative, clinical-stage biopharmaceutical company developing innovative therapeutic options for the...

Rockville, MD, Oct. 02, 2024 (GLOBE NEWSWIRE) -- As per a recently published industry report by Fact.MR, the global single-lead ECG monitor market is estimated to reach a valuation of US$ 669...

Wilmington, Delaware, United States, Transparency Market Research. Inc. , July 01, 2024 (GLOBE NEWSWIRE) -- The global cardiac mapping market stood at US$ 3 billion in 2023, and the global market is...

75% of patients in the rivaroxaban arm voluntarily switched from the once-daily oral anticoagulant to once-monthly abelacimab Landmark AZALEA-TIMI 71 Study previously stopped early due to an...

CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Anthos Therapeutics, Inc. (Anthos), is a clinical-stage company developing innovative therapies for cardiovascular diseases, founded by...

Omaha, Neb., April 08, 2024 (GLOBE NEWSWIRE) -- Nebraska Medicine patient Doris McCann found out something wasn't right with her heart when she got an Apple Watch for Christmas. "I started getting...

Wilmington, Delaware, United States, March 18, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. -The implantable cardiac monitor industry was worth US$ 914.5 million in 2022. By the end of...

Vancouver, Jan. 15, 2024 (GLOBE NEWSWIRE) -- The global arrhythmia monitoring devices market size was USD 7.43 billion in 2022 and is expected to register a rapid revenue CAGR of 7.7% during the...